Clinical implications of immune reconstitution following hematopoietic stem cell transplantation.
Peggs
Karl S
KS
Royal Free and University College London Medical Schools, London, UK. k.peggs@ucl.ac.uk
Krauss
Aviva C
AC
Mackall
Crystal L
CL
D001402:B-Lymphocytes / Q000166:cytology; D016207:Cytokines / Q000378:metabolism; D020350:Graft vs Tumor Effect; D018380:Hematopoietic Stem Cell Transplantation / Q000379:methods* / Q000639:trends; D006412:Hematopoietic Stem Cells / Q000166:cytology; D006801:Humans; D007107:Immune System; D007167:Immunotherapy / Q000379:methods; D008954:Models, Biological; D009369:Neoplasms / Q000628:therapy*; D013601:T-Lymphocytes / Q000166:cytology; D019172:Transplantation Conditioning; D016896:Treatment Outcome
D016207:Cytokines